The Journal of Korean Medicine (대한한의학회지)

The Society of Korean Medicine (대한한의학회)
권호 표지
DOI QR코드

DOI QR Code

A Case Report of Acute Angle Closure Glaucoma Patient Treated with Go-bang

고방(古方)을 통한 급성 폐쇄성 녹내장의 한방치험 1례

  • Received : 2023.02.23
  • Accepted : 2023.05.10
  • Published : 2023.06.01
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: This is a case report on the treatment of one patient with acute angle-closure glaucoma using traditional Korean medicine. Methode: We assessed the progression of acute angle-closure glaucoma by analyzing Optical Coherence Tomography(OCT) results. Results: Acute angle closure glaucoma did not progress to OCT after treatment. Conculsion: We obtained results from OCT examinations indicating that the progression of acute angle-closure glaucoma had ceased after Korean herbal medicine treatment.

Keywords

References

  1. The society of Korean medicine Ophthalmology, Otolaryngology & Dermatology. Text of Traditional Korean Dermatology & Surgery. Seoul:Globooks. 2022:(149-53)
  2. All About Glaucoma: New Diagnostics and Treatment Kim,Yongyeon; Hwang, Younghoon. korea uni. publishing house.2020:(35-79)
  3. Choi JA, New classes of glaucoma medical treatment. J Korean Med Assoc. 2019;62(9):497-504. https://doi.org/10.5124/jkma.2019.62.9.497
  4. Choi YA, Joo BC. Retinal Nerve Fiber Layer Thickness Messured by Spectral Domain Optical Coherence Tomohrapy in Healthy Koreans. J Korean Ophthalamol Soc. 2018;59(6):537-42. https://doi.org/10.3341/jkos.2018.59.6.537
  5. Yakjing Yoshimasu todo original. Kim,Jong-oh Mulgogisup 2021:(35-386)
  6. Hong SK, Sung JK, Kun JY. Clinical Study on Primary Acute Angle Closure Glaucoma. J Korean Ophthalmol Soc. 1995;36(3):139-44.
  7. Choi JA, New classes of glaucoma medical treatment. J Korean Med Assoc. 2019;62(9):497-504. https://doi.org/10.5124/jkma.2019.62.9.497
  8. Kalouda P, Keskini C, Anastasopoulos E, Topouzis F. Achievements and limits of current medical therapy of glaucoma. Dev Ophthalmol. Basel:Karger. 2017:(1-14)
  9. Tanna AP, Johnson M. Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension. Ophthalmology 2018;125(11):1741-56. https://doi.org/10.1016/j.ophtha.2018.04.040
  10. Medeiros FA, Martin KR, Peace J, Scassellati Sforzolini B, Vittitow JL, Weinreb RN. Comparison of latanoprostene bunod 0.024% and timolol maleate 0.5% in open-angle glaucoma or ocular hypertension: the LUNAR study. Am J Opthalmol 2016;168:250-9. https://doi.org/10.1016/j.ajo.2016.05.012
  11. Aung T, Ang LP, Chan SP, Chew PT. Acute primary angle-closure: long-term intraocular pressure outcome in Asian eyes. Am J Ophthalmol 2001;131(1):7-12. https://doi.org/10.1016/S0002-9394(00)00621-8
  12. Khokhar S, Sindhu N, Pangtey MS. Phacoemulsification in filtered chronic angle closure glaucoma eyes. Clin Experiment Ophthalmol. 2002;30(4):256-60. https://doi.org/10.1046/j.1442-9071.2002.00533.x
  13. Lee CH, You IC, Kim YR. Phacoemulsification versus laser peripheral iridotomy in early treatment of acute primary angle-closure glaucoma. J Korean Ophthalmol Soc. 2016;57(2).290-95. https://doi.org/10.3341/jkos.2016.57.2.290
  14. Lai JS, Tham CC, Chan JC. The clinical outcomes of cataract exꠓtraction by phacoemulsification in eyes with primary angle-closure glaucoma (PACG) and co-existing cataract: a prospective case series. J Glaucoma 2006;15(1):47-52. https://doi.org/10.1097/01.ijg.0000196619.34368.0a